CGYO20085 / NRG-CC008 / Richard Moore
Basic Study Information
Purpose:
This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy
and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for
individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal
of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal
of both the fallopian tubes and ovaries. This study may help doctors determine if
the two surgical procedures are nearly the same for ovarian cancer risk reduction
for women with BRCA1 mutations.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Richard Moore
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search